Regular surgery fixes a problem. Cancer surgery does something considerably more involved than that. The margins around the tumour matter as much as the tumour itself, the operation connects directly to chemotherapy or radiation that may follow, and every major decision goes through a team review before the patient even gets a surgery date. That entire framework simply doesn’t exist in routine operative care.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India, “in cancer surgery the operation itself is one step in a longer plan and if that step isn’t executed with the right oncological intent, everything that follows it becomes harder to manage.”

The differences run deeper than technique and touch every part of how the procedure is planned, performed and followed up.

• Surgical Margins: Taking the tumour out isn’t enough on its own because the tissue surrounding it needs to come back clear as well, and when it doesn’t the whole question of whether the cancer was actually removed has to be revisited from the start.
• Pre-Operative Staging: Scans aren’t just background information in cancer surgery  CT, MRI and PET results determine whether laparoscopic cancer surgery is appropriate, whether another approach works better or whether surgery should even happen before other treatments run first.
• Tumour Board Review: A routine operation involves a surgeon and an anaesthetist. A cancer operation involves oncologists, radiologists and radiation specialists all reviewing the plan together before a single decision gets locked in.
• Post-Operative Oncological Care: Recovery from routine surgery is mostly physical but after cancer surgery there’s pathology to review, adjuvant therapy to arrange and a surveillance schedule to maintain because the follow-up period is where recurrence either gets caught early or doesn’t.

What separates cancer surgery from general operative work isn’t just the complexity of the procedure it’s the entire clinical system built around it.

Understanding where the differences actually sit helps patients ask better questions and make more confident decisions about who they want involved in their care.

• Surgeon Selection: A general surgeon and a surgical oncologist both operate, but only one has been specifically trained in oncological margin control, tumour staging and the biology that shapes every intraoperative decision, which matters more than most patients realise going in.
• Treatment Sequencing: Surgery doesn’t always come first in cancer care because some tumours need chemotherapy or radiation to shrink them to a point where robotic cancer surgery can remove them with the precision and margin clearance the case actually requires.
• Recurrence Risk: Every technical decision in cancer surgery from how wide the margins are taken to whether lymph nodes get assessed carries a direct consequence for long-term recurrence risk in a way that simply has no equivalent in routine operative work.
• Integrated Follow-Up: Cancer patients leave theatre with a structured follow-up plan that includes imaging, tumour marker monitoring and coordinated input from multiple specialists because the surgical outcome feeds directly into every decision that comes after it.

Getting the right specialist involved before surgery rather than after is one of the most straightforward ways to avoid a situation where short-term decisions create long-term problems. For a broader understanding of how cancer surgery actually works, cancer surgery is covered separately.

Dr. Sandeep Nayak holds DNB qualifications in Surgical Oncology and General Surgery with a fellowship in Laparoscopic and Robotic Onco-Surgery and 24 years of experience in cases where oncological precision directly determined what was possible for the patient long term. He leads cancer surgery and Robotic Surgery at KIMS Hospital, Bangalore and heads Oncology Services across Karnataka, with originator credits for RABIT, MIND and L-VEIL techniques and over 25 published clinical studies. Patients with complex presentations or cases declined elsewhere are fully assessed here with every operative decision going through tumour board consensus. Call +91 8104310753 to book your consultation.

Reference links:

1. National Cancer Institute — Surgery to Treat Cancer
2. National Institutes of Health — Surgical Oncology and Cancer Treatment

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.

A biopsy is a medical procedure that removes a small sample of tissue, cells, or fluid from the body to be examined under a microscope by a pathologist. It is the most definitive way to diagnose cancer, determine its type, and plan treatment, often performed using needle aspiration, surgical excision, or endoscopic techniques guided by imaging.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India, “we cannot build a proper treatment plan from imaging alone  the biopsy is what tells us the cancer type, the grade and the receptor profile, and every clinical decision after that depends on getting those details right.”

The technique chosen depends on where the tissue is and how much of it is needed to get a reliable answer from the laboratory.

• Fine Needle Aspiration: A thin needle draws cells from the target site without any incision, suitable when the lesion sits close enough to the surface and a preliminary cell assessment is all that’s needed to move the workup forward.
• Core Needle Biopsy: A thicker needle removes a small column of tissue rather than loose cells, which gives pathologists far more material to work with and produces a considerably more accurate reading of tumour grade and receptor characteristics.
• Excisional Biopsy: The whole lump gets surgically removed and sent for analysis, used when it’s small enough to take out entirely or when needle samples have repeatedly failed to give a clear enough answer to act on.
• Endoscopic Biopsy: A flexible scope passes through a natural body opening to reach and sample tissue in the oesophagus, stomach or bowel, and where deeper abdominal access is needed, laparoscopic cancer surgery techniques make it possible to reach the site with minimal disruption to surrounding structures.

The biopsy method isn’t chosen arbitrarily; it comes down to what the clinical team needs from the sample and which technique can actually deliver that from the location in question.

Getting the sample is only the first part. What happens in the laboratory afterward is where the clinically actionable information actually comes from.

• Histopathology: The tissue is processed, stained and examined by a pathologist who determines whether cancer cells are present, identifies the tumour type and assesses how abnormal the cells look relative to healthy tissue in the same area.
• Receptor and Gene Testing: Breast, lung and several other cancer types get tested for hormone receptors, HER2 status and specific mutations because those results are what determine whether robotic cancer surgery alone is sufficient or whether targeted therapy needs to run alongside or before it.
• Staging Correlation: The pathology report doesn’t get read in isolation  it’s placed alongside scan findings and clinical examination to confirm how far the cancer has spread, which is what determines whether surgery or systemic treatment should come first.
• Tumour Board Review: Before any plan reaches the patient, the full biopsy report goes in front of a multidisciplinary team where surgeons, oncologists and radiologists interpret everything together, because individual results don’t drive decisions the full picture does.

Turnaround time varies from a few days for standard histopathology to a couple of weeks when molecular testing is included, and for a clearer sense of how biopsy findings connect to surgical decisions, cancer surgery is covered separately.

Dr. Sandeep Nayak holds DNB qualifications in Surgical Oncology and General Surgery with a fellowship in Laparoscopic and Robotic Onco-Surgery and 24 years of experience in cases where accurate early diagnosis shaped what remained possible for the patient surgically and systemically. He leads cancer surgery and Robotic Surgery at KIMS Hospital, Bangalore and heads Oncology Services across Karnataka, with originator credits for RABIT, MIND and L-VEIL techniques and over 25 published clinical studies. Patients who need a second opinion on a biopsy result, clarification on a diagnosis or a full surgical assessment are seen here with every decision reviewed through tumour board consensus before it reaches them. Call +91 8104310753 to book your consultation.

Reference links:

1. National Cancer Institute — Biopsy for Cancer Diagnosis
2. National Institutes of Health — Pathological Diagnosis in Oncology

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.

Cancer surgery isn’t one procedure applied the same way across every case. Some operations aim to remove the disease entirely, others are done just to confirm what the cancer actually is, and some are performed specifically to make the patient more comfortable when cure is no longer possible. The type recommended depends on how far the cancer has progressed and what the treatment is realistically trying to achieve.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India, “getting the surgical type right matters as much as getting the technique right operating with the wrong intent at the wrong stage doesn’t help the patient, it just adds risk.”

The primary types differ in purpose and each one is selected based on what stage the disease has reached and what the clinical team is trying to accomplish.

• Curative Surgery: The cancer is localised and the aim is to take it out completely with clean margins around it, which gives the patient the best realistic shot at the disease not coming back after the operation.
• Debulking Surgery: Full removal isn’t on the table because of where the tumour sits or how much it has grown, so surgeons remove as much as safely possible to make robotic cancer surgery or follow-up treatment more effective on whatever is left.
• Diagnostic Surgery: A biopsy or small excision takes tissue out for lab testing because without knowing exactly what kind of cancer it is and how aggressive, no treatment plan can be built on solid ground.
• Palliative Surgery: The disease has advanced beyond the point where operating can change its course, so the procedure focuses on specific complications like a blocked bowel or a tumour pressing on a nerve to keep the patient functioning as well as possible.

These four types cover the majority of cancer surgical decisions and every recommendation goes through a full multidisciplinary team review before anything is finalised.

A number of other procedures run alongside the main surgical types and each one fills a specific gap depending on where the patient is in their treatment journey.

• Preventive Surgery: Patients with a confirmed high genetic risk such as BRCA mutations may be offered surgery to remove tissue that hasn’t yet become cancerous, based on a documented risk assessment rather than any current diagnosis.
• Reconstructive Surgery: After a major resection removes tissue in areas like the breast or jaw, reconstruction work restores appearance and function, and laparoscopic cancer surgery during the primary procedure helps keep that reconstruction manageable by limiting initial tissue loss.
• Staging Surgery: When scans alone can’t give the full picture of how far the cancer has spread, a surgeon physically examines the surrounding tissue and nodes to get the information needed to make the next treatment decision.
• Supportive Surgery: Port insertion for chemotherapy delivery, feeding tube placement, or other procedures that don’t directly target the cancer but make it possible for the patient to get through the rest of their treatment without their condition deteriorating further.

These procedures don’t replace the primary operation but they’re often just as important to the overall outcome, and for a clearer sense of how the full surgical picture fits together, cancer surgery is covered separately.

Dr. Sandeep Nayak holds DNB qualifications in Surgical Oncology and General Surgery with a fellowship in Laparoscopic and Robotic Onco-Surgery and 24 years of experience across every category of cancer surgery from straightforward curative resections through to complex palliative and reconstructive cases. He heads Oncology Services across Karnataka and leads Surgical Oncology and Robotic Surgery at KIMS Hospital, Bangalore, with originator credits for RABIT, MIND and L-VEIL techniques and over 25 published clinical studies behind him. Patients with complex presentations, rare tumours or cases that other centres have declined get a full assessment here with every operative decision made through tumour board consensus and outcomes tracked against real data. Call +91 8104310753 to book your consultation.

References

1. National Cancer Institute — Types of Cancer Surgery
2. National Institutes of Health — Surgical Approaches in Oncology

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.

A surgical oncologist is not a general surgeon who occasionally removes tumours. The training is specific to cancer, covering how tumours behave, how margins affect outcomes and how surgery connects to everything else in the treatment plan. Most solid tumour cancers, breast, colon, liver, pancreas, thyroid and head and neck, are managed within this specialty.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India, “patients often come in thinking any surgeon can handle their cancer case, but the decisions made in theatre and around it are fundamentally different when oncological outcomes are the goal.”

The role goes well beyond operating and covers clinical decisions at every stage of the cancer treatment journey.

• Tumour Assessment: Before any operation is planned, scans, biopsy findings and staging results are reviewed together to work out whether surgery will genuinely benefit the patient or whether a different approach makes more sense first.
• Operative Management: The choice between open, laparoscopic or robotic surgery comes down to where the tumour is, how far it has spread and what level of perioperative risk the patient can reasonably carry going into theatre.
• MDT Participation: No complex cancer case gets decided by one person alone because the surgical pathway always goes through a multidisciplinary team where oncologists, radiologists and radiation specialists all agree on the plan first.
• Post-Operative Care: Once surgery is done, pathology results are reviewed, follow-up treatment is arranged where needed and surveillance runs on a fixed schedule because picking up any change in the disease early genuinely changes what options are still available.

Getting a surgical oncologist involved at the right time is one of the clearest factors that separates a treatment plan built on solid clinical ground from one that’s making things up as it goes.

Solid tumours across most organ systems fall within this specialty and the technical approach varies considerably depending on which site is involved.

• GI Cancers: Colon, rectal, stomach, oesophageal and pancreatic cancers all land here with procedures like bowel resection, gastrectomy and Whipple surgery chosen based on how far the disease has spread and which structures around the tumour are involved.
• Breast Cancer: Surgery ranges from removing just the lump through to full mastectomy with axillary clearance, and breast cancer treatment decisions are driven by the tumour’s receptor profile and nodal burden rather than size alone.
• Hepatobiliary Cancers: Liver resections, bile duct surgery, adrenal tumours and retroperitoneal sarcomas sit here and these are genuinely complex cases that need a surgeon with high specific operative volume and the institutional backup to handle complications.
• Head, Neck and Thyroid: Oral cancers, thyroid malignancies, laryngeal tumours and neck dissections are managed within this domain, and robotic cancer surgery has materially changed what’s achievable here in terms of precision and how patients recover afterward.

Gynaecological and thoracic cancers also fall within the scope depending on training and setup, and for a full account of how cancer surgery works in practice, cancer surgery is covered separately.

Dr. Sandeep Nayak holds DNB qualifications in Surgical Oncology and General Surgery with a fellowship in Laparoscopic and Robotic Onco-Surgery and 24 years of experience managing cancer cases that span multiple organ systems and levels of complexity. He heads Oncology Services across Karnataka and leads surgical oncology and Robotic Surgery at KIMS Hospital, Bangalore, with originator credits for RABIT, MIND and L-VEIL techniques and over 25 published clinical studies. Cases involving rare tumours, multi-organ disease or situations where other centres have turned patients away are assessed here with operative decisions going through tumour board consensus every time. Call +91 8104310753 to book your consultation.

Reference links:

1. National Cancer Institute — Surgical Oncology Overview
2. National Institutes of Health — Role of Surgery in Cancer Treatment

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.

Cancer surgery removes malignant tissue or entire tumours to treat, confirm, or manage the disease. It’s the most direct approach for solid tumour cancers. Whether it’s recommended comes down to tumour stage, anatomical location, and how well the patient can clinically tolerate the procedure.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India, “surgery is recommended not just when a tumour exists, but when its complete or meaningful removal is achievable without unacceptable risk to the patient.”

Cancer surgery is classified by intent. The approach differs considerably depending on what the surgery is meant to achieve.

• Curative: Removes the tumour entirely with clear histological margins when disease is confined to the primary site and hasn’t breached surrounding critical anatomy.
• Debulking: Applied when full excision isn’t surgically possible  reduces tumour load so chemotherapy or radiation has less residual disease to work against.
• Diagnostic: Tissue extraction through core-needle or excisional biopsy; laparoscopic cancer surgery is used when deep-seated lesions need access with minimal operative trauma.
• Palliative: Addresses complications like bowel obstruction or biliary blockage in advanced cases. Not about cure. About function and quality of remaining life.

Surgical intent goes through tumour board review first. No unilateral calls here.

Surgery gets recommended when the full clinical picture imaging, pathology, fitness confirms it’ll do more good than harm.

• Stage at Diagnosis: Stage I and II localised tumours are the strongest candidates. The earlier the intervention, the higher the probability of durable disease control before spread occurs.
• Resectability: CT, MRI, and PET-CT determine proximity to major vessels or visceral structures. A technically unresectable tumour doesn’t go to theatre regardless of stage.
• Post-Neoadjuvant Candidacy: Some tumours only become operable after chemotherapy or radiation shrinks them enough resectability isn’t always a fixed status at first assessment.
• Pre-Operative Fitness: Cardiac reserve, lung function, serum albumin, and performance status are all evaluated together. Medical unfitness stops the surgical pathway regardless of tumour operability.

Surgery doesn’t always come first. But for most solid tumour cancers, it anchors everything that follows. For more on robotic surgery, this is covered separately in detail.

Dr. Sandeep Nayak holds DNB qualifications in Surgical Oncology and General Surgery, with a fellowship in Laparoscopic and Robotic Onco-Surgery and over 24 years across genuinely complex oncological cases. He heads Oncology Services across Karnataka and leads Surgical Oncology and Robotic Surgery at KIMS Hospital, Bangalore. Published 25+ studies. Originator of RABIT, MIND, and L-VEIL techniques. Cases involving multi-organ disease or those turned away elsewhere are assessed here decisions made through tumour board consensus, outcomes tracked. Call +91 8104310753 to book your consultation.

Reference links:

1. National Cancer Institute — Surgery to Treat Cancer
2. World Health Organization — Cancer Treatment Overview

• Disclaimer: The information shared in this content is for educational purposes and not for promotional use.